Assignee
CELL THERAPEUTICS INC
US93 patents
Top patents by PatentIndex Score
US5780476AJul 14, 1998
Hydroxyl-containing xanthine compounds
CELL THERAPEUTICS INC95 citations98
US5807861ASep 15, 1998
Amine substituted xanthinyl compounds
CELL THERAPEUTICS INC106 citations97
US5804584ASep 8, 1998
Therapeutic compounds containing a monocyclic five- to six- membered ring structure having one to two nitrogen atoms
CELL THERAPEUTICS INC39 citations96
US5648357AJul 15, 1997
Enatiomerically pure hydroxylated xanthine compounds
CELL THERAPEUTICS INC59 citations96
US5641783AJun 24, 1997
Substituted amino alcohol compounds
CELL THERAPEUTICS INC57 citations96
US5470878ANov 28, 1995
Cell signaling inhibitors
CELL THERAPEUTICS INC74 citations96
US5929081AJul 27, 1999
Method for treating diseases mediated by cellular proliferation in response to PDGF, EGF, FGF and VEGF
CELL THERAPEUTICS INC44 citations95
US5859018AJan 12, 1999
Method for treating diseases mediated by cellular proliferation in response to PDGF, EGF, FGF, and VEGF
CELL THERAPEUTICS INC67 citations95
US5817662AOct 6, 1998
Substituted amino alkyl compounds
CELL THERAPEUTICS INC47 citations95
US5807862ASep 15, 1998
Therapeutic compounds containing pyrimidinyl moieties
CELL THERAPEUTICS INC53 citations95
US5795898AAug 18, 1998
Method for treating diseases mediated by cellular proliferation in response to PDGF,EGF,FGF and VEGF
CELL THERAPEUTICS INC48 citations95
US5340813AAug 23, 1994
Substituted aminoalkyl xanthine compounds
CELL THERAPEUTICS INC52 citations95
US5777115AJul 7, 1998
Acetal-and ketal-substituted pyrimidine compounds
CELL THERAPEUTICS INC46 citations94
US7208507B2Apr 24, 2007
Pyridines and uses thereof
CELL THERAPEUTICS INC22 citations93
US7052891B2May 30, 2006
Human lysophoshatidic acid acyltransferase gamma-1 polypeptide
CELL THERAPEUTICS INC53 citations93
US6875781B2Apr 5, 2005
Pyridines and uses thereof
CELL THERAPEUTICS INC34 citations93
US7618968B2Nov 17, 2009
Aryl triazines as LPAAT-β inhibitors and uses thereof
CELL THERAPEUTICS INC24 citations92
US7291616B2Nov 6, 2007
Aryl triazines as LPAAT-β inhibitors and uses thereof
CELL THERAPEUTICS INC26 citations92
US6878715B1Apr 12, 2005
Therapeutic compounds for inhibiting interleukin-12 signals and method for using same
CELL THERAPEUTICS INC46 citations92
US6774130B2Aug 10, 2004
Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using same
CELL THERAPEUTICS INC22 citations92
US6469017B1Oct 22, 2002
Method of inhibiting interleukin-12 signaling
CELL THERAPEUTICS INC17 citations92
US6133274AOct 17, 2000
Hydroxyl-containing bicyclic compounds
CELL THERAPEUTICS INC26 citations92
US6020337AFeb 1, 2000
Electronegative-substituted long chain xanthine compounds
CELL THERAPEUTICS INC36 citations92
US5965564AOct 12, 1999
Enantiomerically pure hydroxylated xanthine compounds
CELL THERAPEUTICS INC19 citations92
US5856331AJan 5, 1999
Method for preventing tissue injury from hypoxia
CELL THERAPEUTICS INC26 citations92
US5837703ANov 17, 1998
Amino-alcohol substituted cyclic compounds
CELL THERAPEUTICS INC33 citations92
US5801181ASep 1, 1998
Amino alcohol substituted cyclic compounds
CELL THERAPEUTICS INC38 citations92
US5792772AAug 11, 1998
Enatiomerically pure hydroxylated xanthine compounds
CELL THERAPEUTICS INC18 citations92
US5770595AJun 23, 1998
Oxime substituted therapeutic compounds
CELL THERAPEUTICS INC40 citations92
US5739138AApr 14, 1998
Enantiomerically pure hydroxylated xanthine compounds to treat autoimmune diabetes
CELL THERAPEUTICS INC19 citations92
US5670506ASep 23, 1997
Halogen, isothiocyanate or azide substituted xanthines
CELL THERAPEUTICS INC43 citations92
US5652243AJul 29, 1997
Methods of using enantiomerically pure hydroxylated xanthine compounds
CELL THERAPEUTICS INC18 citations92
US5629423AMay 13, 1997
Asymmetric synthesis of chiral secondary alcohols
CELL THERAPEUTICS INC21 citations92
US5629315AMay 13, 1997
Treatment of diseases using enantiomerically pure hydroxylated xanthine compounds
CELL THERAPEUTICS INC19 citations92
US5621102AApr 15, 1997
Process for preparing enantiomerically pure xanthine derivatives
CELL THERAPEUTICS INC22 citations92
US5620984AApr 15, 1997
Enatiomerically pure hydroxylated xanthine compounds to treat inflammatory diseases
CELL THERAPEUTICS INC21 citations92
US5580873ADec 3, 1996
Enatiomerically pure hydroxylated xanthine compounds to treat proliferative vascular diseases
CELL THERAPEUTICS INC23 citations92
US5288721AFeb 22, 1994
Substituted epoxyalkyl xanthines
CELL THERAPEUTICS INC31 citations92
US5801182ASep 1, 1998
Amine substituted compounds
CELL THERAPEUTICS INC50 citations91
US7419984B2Sep 2, 2008
Pyrimidines and uses thereof
CELL THERAPEUTICS INC26 citations90
US6316458B1Nov 13, 2001
Method of enhancing insulin action
CELL THERAPEUTICS INC31 citations88
US5780237AJul 14, 1998
Sepsis, adult respiratory distress syndrome, and systemic inflammatory response syndrome diagnostic
CELL THERAPEUTICS INC52 citations88
US5985926ANov 16, 1999
Method for inhibiting intracellular viral replication
CELL THERAPEUTICS INC20 citations84
US5756511AMay 26, 1998
Method for treating symptoms of a neurodegenerative condition
CELL THERAPEUTICS INC19 citations84
US5777117AJul 7, 1998
Method for preparing substituted amino alcohol compounds
CELL THERAPEUTICS INC15 citations82
US5580874ADec 3, 1996
Enatiomerically pure hydroxylated xanthine compounds
CELL THERAPEUTICS INC14 citations82
US5866576AFeb 2, 1999
Epoxide-containing compounds
CELL THERAPEUTICS INC15 citations81
US6503700B1Jan 7, 2003
Mammalian CDP-diacylglycerol synthase
CELL THERAPEUTICS INC6 citations74
US6075029AJun 13, 2000
Xanthine modulators of metabolism of cellular P-450
CELL THERAPEUTICS INC12 citations74
US5750575AMay 12, 1998
Substituted amino alcohol compounds
CELL THERAPEUTICS INC4 citations74
Showing the top 50 of 93 patents by PatentIndex Score.